NEW YORK (GenomeWeb News) — Genologics Life Sciences yesterday said it has closed a second round of private equity financing.
 
Genologics said it plans to use the undisclosed funding primarily to market its bioinformatics software to pharmaceutical labs specializing in proteomics, genomics, and systems biology research.
 
The financing was led by OVP Venture Partners and included investments from Growth Works and Yaletown Venture Partners.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.